Restore-1 Clinical Study

A randomized, placebo surgery controlled, double-blinded, multi-center, Phase 2 Clinical Trial, evaluating the efficacy and safety of VY-AADC02 in Advanced Parkinson’s Disease with Motor Fluctuations

Restore-1 Clinical Study

Principal Investigator: Chadwick Christine, M.D.

Co-Principal Investigator: Paul Larson, M.D.

Contact: Marin Thompson, MS., CCRP.

415-353-9666

[email protected]

 

https://clinicaltrials.gov/ct2/show/NCT03562494